Abstract
Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the development of invasive breast cancer. This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.
Copyright © 2018 by the National Comprehensive Cancer Network.
MeSH terms
-
Breast Neoplasms / diagnosis*
-
Breast Neoplasms / etiology
-
Breast Neoplasms / therapy*
-
Carcinoma, Ductal, Breast / diagnosis
-
Carcinoma, Ductal, Breast / etiology
-
Carcinoma, Ductal, Breast / therapy
-
Carcinoma, Intraductal, Noninfiltrating / diagnosis
-
Carcinoma, Intraductal, Noninfiltrating / etiology
-
Carcinoma, Intraductal, Noninfiltrating / therapy
-
Combined Modality Therapy
-
Disease Management
-
Female
-
Humans
-
Retreatment
-
Treatment Outcome
-
Watchful Waiting